Company Profiles

driven by the PitchBook Platform

Chroma Therapeutics

Description

Developer of biotechnology products for cancer treatment. The company engages in discovery and development of small molecule drugs based upon chromatin biology and cell accumulation approaches which aims at the treatment of high-prevalence cancers and inflammatory disorders.

2000

Founded

PRIVATE

Status

51-200

Employees

Senior Debt

Latest Deal Type

$15M

Latest Deal Amount

$113M

Total Amount Raised

Description

Developer of biotechnology products for cancer treatment. The company engages in discovery and development of small molecule drugs based upon chromatin biology and cell accumulation approaches which aims at the treatment of high-prevalence cancers and inflammatory disorders.

Website:

www.chromatherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

93 Innovation Drive Milton Park, Abingdon Milton OX14 4RYEngland +44 (0)12 3582 9120
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Chroma Therapeutics's full profile, request a free trial.

Chroma Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Chroma Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Chroma Therapeutics Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Abingworth ManagementVenture CapitalMinority000 0000000 0000
Cambridge EnterpriseVenture CapitalMinority000 0000000 0000
Cancer Research TechnologyVenture CapitalMinority000 0000000 0000
Essex WoodlandsGrowth/ExpansionMinority000 0000000 0000
Gilde Healthcare PartnersVenture CapitalMinority000 0000000 0000
Abingworth Management Venture Capital
Cambridge Enterprise Venture Capital
Cancer Research Technology Venture Capital
Essex Woodlands Growth/Expansion
Gilde Healthcare Partners Venture Capital

Chroma Therapeutics Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Alan DavidsonDirector, Pre-Clinical Development (consultant)
Martin ToalChief Medical Officer
Richard BungayChief Executive Officer & Board Member
Alan Davidson Director, Pre-Clinical Development (consultant)
Martin Toal Chief Medical Officer
Richard Bungay Chief Executive Officer & Board Member

Chroma Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Leo YipSelfBoard Member000 0000
Peter AllenSelfChairman of Board000 0000
Richard BungaySelfChief Executive Officer & Board Member000 0000
Steven Powell Ph.DGilde Investment ManagementBoard Member000 0000
Timothy HainesAbingworth ManagementManaging Partner000 0000
Leo Yip Board Member Self
Peter Allen Chairman of Board Self
Richard Bungay Chief Executive Officer & Board Member Self
Steven Powell Ph.D Board Member Gilde Investment Management
Timothy Haines Managing Partner Abingworth Management
Request full access to PitchBook